REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)

CUSIP: 75886F107

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
103,945,862
Total 13F shares
92,030,457
Share change
-1,690,366
Total reported value
$58,330,479,204
Put/Call ratio
101%
Price per share
$634.23
Number of holders
1,275
Value change
-$1,189,685,324
Number of buys
648
Number of sells
590

Security key

75886F107

Report period

Q1 2025

Institutions

1,275

Top holders

10

Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
8.9%
9,286,346
$6,614,942,845 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
8.4%
8,731,622
$6,219,796,349 31 Dec 2024
13F
FMR LLC
13F
Company
7.9%
8,199,579
$5,840,806,944 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
6.8%
7,059,371
$5,028,602,870 31 Dec 2024
13F
STATE STREET CORP
13F
Company
4.6%
4,832,239
$3,441,859,354 31 Dec 2024
13F
Capital International Investors
13F
Company
4.6%
4,736,929
$3,373,859,362 31 Dec 2024
13F
Capital World Investors
13F
Company
2.7%
2,778,980
$1,979,491,233 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
2,427,630
$1,726,940,418 31 Dec 2024
13F
DODGE & COX
13F
Company
2.2%
2,321,316
$1,653,543,026 31 Dec 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
2%
2,085,447
$1,485,527,000 31 Dec 2024
13F
FRANKLIN RESOURCES INC
13F
Company
2%
2,045,210
$1,456,864,439 31 Dec 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
1.5%
1,575,349
$1,122,168,000 31 Dec 2024
13F
Amundi
13F
Individual
1.5%
1,551,735
$1,138,073,529 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
1.4%
1,430,370
$1,018,898,036 31 Dec 2024
13F
NORGES BANK
13F
Company
1.1%
1,125,933
$802,035,854 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
1%
1,054,829
$751,386,341 31 Dec 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.94%
982,064
$699,553,650 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.9%
940,198
$669,731,480 31 Dec 2024
13F
Invesco Ltd.
13F
Company
0.83%
864,249
$615,630,811 31 Dec 2024
13F
Legal & General Group Plc
13F
Company
0.75%
777,477
$553,820,199 31 Dec 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.68%
707,546
$504,007,289 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.67%
695,799
$495,638,706 31 Dec 2024
13F
Bank of New York Mellon Corp
13F
Company
0.66%
689,263
$490,982,845 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.62%
644,637
$459,194,739 31 Dec 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.6%
623,156
$443,892,713 31 Dec 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.56%
587,025
$418,113,258 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.52%
539,596
$384,370,419 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.52%
539,269
$384,137,488 31 Dec 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.49%
511,556
$364,396,000 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.48%
500,230
$356,328,836 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.46%
475,630
$338,805,518 31 Dec 2024
13F
Neuberger Berman Group LLC
13F
Company
0.44%
462,529
$329,473,530 31 Dec 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.42%
441,654
$314,603,394 31 Dec 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.42%
433,804
$308,586,771 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.37%
385,178
$274,373,842 31 Dec 2024
13F
UBS Group AG
13F
Company
0.37%
382,835
$272,704,855 31 Dec 2024
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.35%
363,496
$258,929,106 31 Dec 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.35%
359,389
$256,003,567 31 Dec 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.34%
356,410
$253,875,721 31 Dec 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.31%
326,551
$232,397,127 31 Dec 2024
13F
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC
13F
Company
0.3%
310,153
$220,931,297 31 Dec 2024
13F
Swiss National Bank
13F
Company
0.29%
306,300
$218,186,679 31 Dec 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.29%
302,616
$215,562,455 31 Dec 2024
13F
ROYAL BANK OF CANADA
13F
Company
0.28%
288,937
$205,820,000 31 Dec 2024
13F
FIRST TRUST ADVISORS LP
13F
Company
0.26%
272,592
$194,175,137 31 Dec 2024
13F
S.c.a. Candriam
13F
Individual
0.25%
261,498
$186,272,870 31 Dec 2024
13F
Squarepoint Ops LLC
13F
Company
0.24%
254,579
$181,344,259 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.24%
247,743
$176,474,771 31 Dec 2024
13F
CANADA PENSION PLAN INVESTMENT BOARD
13F
Company
0.23%
243,473
$173,433,122 31 Dec 2024
13F
National Pension Service
13F
Company
0.22%
232,450
$165,581,109 31 Dec 2024
13F

Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q1 2025

As of 31 Mar 2025, REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by 1,275 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,030,457 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, Dodge & Cox, FRANKLIN RESOURCES INC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 1,285 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
1,299
Q1 2025 holders
1,275
Holder diff
-24
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .